News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Fibonacci sequence inspires new brand identity for The Institute of Cancer Research
The Fibonacci sequence and images inspired by science and medicine feature prominently in a bold rebranding of The Institute of Cancer Research, London.
The Institute of Cancer Research (ICR) is one of the world’s most influential cancer research institutes, and its new visual identity is intended to help it develop the profile to match.
Multimillion pound fund's cancer research donations should help deliver real benefits to cancer patients
The Institute of Cancer Research will be the main charitable beneficiary of an innovative multimillion pound investment fund.
Targeted therapy may benefit men whose prostate cancer has spread to their bones
A new-generation cancer drug could shrink prostate tumours that have spread to patients’ bones and help to relieve bone pain, trial results suggest.
Paul Workman features in BBC Radio 4 science special
Professor Paul Workman discusses the issues facing the pharmaceutical industry – and the role that non-profit and academic organisations like the ICR can play in driving drug discovery progress – in a BBC Radio 4 special.
Professor Philip Lawley
Distinguished ICR scientist Professor Philip Lawley died recently at the age of 84. His former ICR colleague Dr Stan Venitt, Emeritus Reader in Cancer Studies, reflects on an accomplished and dedicated man who gave the world the first convincing evidence that DNA damage was the basic cause of cancer.
ICR Scientific Image Competition
The annual ICR Scientific Image Competition provides our scientists and students an opportunity to share the importance of their research through the visual means of images gathered during the research process.
Looking at the winning entries in this year's competition, it is hard not to feel that you are viewing artwork.
Longer Lives for Multiple Myeloma Patients
Multiple Myeloma affects around 4000 people each year. The average survival time after diagnosis is just three to five years, so new treatment options are urgently needed
Male breast cancer-causing gene found
The world’s largest study into the causes of male breast cancer has found a gene that can increase the risk of the disease by up to 50 per cent.
New drug type could boost chemotherapy
Scientists at The Institute of Cancer Research, in conjunction with cancer drug discovery company Sareum, have shown that a new type of drug could boost the effectiveness of chemotherapy treatments for many cancer types.
Whole-genome scan helps select best treatment for childhood cancer
A whole-genome scan to identify large-scale chromosomal damage can help doctors choose the best treatment option for children with neuroblastoma, finds a study led by the ICR.
Funding injection into prostate cancer research
Prostate cancer researchers at The Institute of Cancer Research, London, are launching two new collaborations that will make use of cutting-edge genetic technology to help improve patients’ treatment options, thanks to a $750,000 funding boost.
Epigenetic drug discovery collaboration announced
Astex, CRT and the ICR have initiated a collaboration to discover and develop drug candidates targeting an undisclosed epigenetic target in a blood cancer with high unmet medical need.
